Skip to main content
Midas Edge

OptimizeRx Corp

For the period ended Sep 30, 2024. Filed Nov 14, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 14, 2024

OPRX$9.35-1.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 1. Financial Statements (unaudited)

Item 1. Financial Statements

Our condensed consolidated financial statements included in this Form 10-Q are as follows:

2Condensed Consolidated Balance Sheets as of September 30, 2024 (unaudited) and December 31, 2023 (unaudited);
3Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2024 and 2023 (unaudited);
4Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three and nine months September 30, 2024 and 2023 (unaudited);
6Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2024 and 2023 (unaudited);
7Notes to Condensed Consolidated Financial Statements (unaudited).
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.